Robert Delaune works in the field of Hematology. He went to University of Texas Southwestern Medical School. He received awards:"Meaningful Use Stage 1 Certification" and "Top MD". Robert Delaune is also published. He has 5 publications published. The lastest publication: "Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome...' He accepts Medicare.
NPI NUMBER | 1497723514 | |
NPPES Provider LastName | DELAUNE | |
NPPES Provider FirstName | ROBERT | |
NPPES Provider ZIPCode | 551091127 | |
NPPES Provider State | MN | |
Specialty Description | Medical Oncology | |
Total Claim Count | 1339.0 | |
Distinct Opioid Count | 3.0 | |
Opioid Claim Count | 118.0 | |
Percent Opioid Claims | 8.81 |
National Provider Identifier [NPI] | 1497723514 |
Last Name Of The Provider | DELAUNE |
First Name Of The Provider | ROBERT |
View All |
Dr. Kenneth C. Caldwell, MD | |
Dr. Ann M. Connor, MD | |
Dr. Kathleen D. Siechen, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Anna E. Schorer, MD | |
Dr. Lorre A. Ochs, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Phyllis J. Sabol, MD | |
Mary E. Jarvis, LICSW |